Last reviewed · How we verify

NCT06631118

Pericapsular Nerve Block Versus Propofol During Hip Fractures Surgery

Not yet recruiting NA Last updated 8 October 2024
What this trial tests

NA trial testing pericapsular nerve group block for group A,low dose intravenous Propofol [0.7mg/kg] over 30 seconds for group B in Difference in Reduction in Visual Analogue Score at 30 Minutes in 60 participants. Not yet recruiting.

Timeline
21 October 2024
Primary endpoint
31 January 2025
15 February 2025

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment60
Start date21 October 2024
Primary completion31 January 2025
Estimated completion15 February 2025

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 40 to 70, any sex, with Difference in Reduction in Visual Analogue Score at 30 Minutes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will compare the efficacy of Pericapsular nerve group block (PENG) versus low dose Propofol for the achievement of painless sitting position before spinal anesthesia in patients undergoing repair of Hip fractures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06631118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing